BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

SEA Countries

Gene Solutions' multi-cancer early detection shows promise in Southeast Asia's biotech industry.

Circulating tumor DNA, or cell-free tumor DNA (ctDNA) assay is based on detecting the appearance of ctDNA in blood. This method is sometimes called Liquid ...

April 26, 2023 | News

CPHI Japan: the rise of Chinese innovation the big macro story for APAC in 2023

“Historically, we have seen a dual strategy of focusing on China and the US for emerging innovators in China. However, a series of recent setbacks wi...

April 13, 2023 | News

FINN Partners & Galen Growth will Host Digital Health Investment Summit in Boston

Digital Health Funding in Massachusetts Continues to Thrive Led by Investment in Key Therapeutic Areas Galen Growth, the...

April 12, 2023 | News

Partnership agreement to commercialize new anti-PD1 antibody in Australia and Southeast Asia signed by Specialised Therapeutics

The therapy ANNIKO® (penpulimab) is an anti-PD1 monoclonal antibody currently under regulatory review by the US FDA for nasopharyngeal carcinoma &...

April 12, 2023 | News

Pharma marketing future and present: AI & Modular Content in APAC focus

At the same time, it is crucial to understand that the implementation of AI and ML technologies requires eradicative change within the whole company struct...

March 31, 2023 | News

Earable Neuroscience and Excelpoint Partner to Commercialize AI-Powered FRENZ Brainband for Global Sleep Pandemic

Since the COVID-19 pandemic began, researchers around the world have documented a surge in sleep disorders which affect overall health, safety and qualit...

March 31, 2023 | News

The Rapidly Growing Biopharma Industry in Southeast Asia: Which Countries are Leading the Way?

Singapore: A Biopharma Hub Singapore is one of the most prominent players in the Southeast Asian biopharma industry. It has positioned itself as a hub for...

March 31, 2023 | News

Rxilient Biotech and Junshi Biosciences form Joint Venture to develop and commercialize Toripalimab in Southeast Asia

Toripalimab is an anti-PD-1 monoclonal antibody independently developed by Junshi Biosciences. Junshi Biosciences has conducted over 30 clinical tr...

March 31, 2023 | News

Aptamer Group's Optimer-Fc: An Innovative Solution to Enhance Accuracy of Automated IHC Workflows

Aptamer Group's Chief Technical Officer, Dr David Bunka, speaks to BioPharma APAC about the innovative Optimer-Fc reagent solution for immunohistochemistry...

March 29, 2023 | Influencers

Asians Prioritize Health Span to Boost Retirement Well-being, Reveals Manulife Survey

Survey of 7,000+ people in Asia shows expectation of early retirement, early deterioration in health Concerns about cost of well-being nu...

March 29, 2023 | News

Vetter Performs Extraordinarily with Six Wins in the 12th Annual CDMO Leadership Awards

▪ Vetter celebrates its second consecutive year earning this award in six categories with three additional honors in the CDMO Leadership Awards&nbs...

March 28, 2023 | News

Indian Immunologicals Limited receives regulatory approval for Measles-Rubella (MR) Vaccine

Indian Immunologicals Limited (IIL), a leading vaccine manufacturer has announced receipt of approval from Drugs Controller General of India and State...

March 28, 2023 | News

Amgen and NSG Biolabs award first Golden Ticket in Singapore to Albatroz Therapeutics

Leading global biotechnology company Amgen and NSG BioLabs, Singapore's largest and leading provider of biotechnology (biotech) co-working labora...

March 20, 2023 | News

"Fueling Growth and Innovation: The Rise of Biotech Investment in the Asia Pacific Region"

According to a report by Deloitte, the APAC biotech market is expected to grow at a compound annual growth rate (CAGR) of 10.9% between 2020 and 2025, with...

February 20, 2023 | News

Stay Connected